Foscarnet sodium
Foscarnet sodium
CLINICAL USE
Antiviral agent:Treatment and maintenance therapy of cytomegalovirus retinitis (CMV)Mucocutaneous herpes simplex infection (HSI)
DOSE IN NORMAL RENAL FUNCTION
CMV: 60 mg/kg every 8 hours induction dose for 2–3 weeks, then 60 mg/kg daily, increase to 90–120 mg/kg if toleratedMucocutaneous herpes simplex infection: 40 mg/kg every 8 hours
PHARMACOKINETICS
Molecular weight                           :300 %Protein binding                           :14–17 %Excreted unchanged in urine     : 85 Volume of distribution (L/kg)       :0.4–0.6half-life – normal/ESRD (hrs)      :2–4/>100 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : 28 mg/kg every 8 hours 10 to 20     : 15 mg/kg every 8 hours <10           : 6 mg/kg every 8 hours DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Dialysed. Dose as in GFR <10           : mL/min. See ‘Other Information’ HD                     :Dialysed. Dose as in GFR <10           : mL/min. See ‘Other Information’HDF/high flux   :Dialysed. Dose as in GFR <10           : mL/min. See ‘Other Information’CAV/VVHD      :Dialysed. Dose as in GFR=10–20 mL/min. IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntivirals: avoid with lamivudine Ciclosporin: may cause acute renal failure in combination ADMINISTRATION
Reconstition
– Route
Centrally (undiluted); peripherally (diluted) Rate of Administration
Continuous infusion over 24 hours, or intermittent infusion over at least 60 minutesComments
If given peripherally dilute with glucose 5% or sodium chloride 0.9% to a concentration of 12 mg/mL or lessAlternatively, piggy-back the undiluted foscarnet dose to 1 litre of a glucose 5% or sodium chloride 0.9% infusionIf given centrally, can be administered undiluted but additional fluids should be given to reduce the risk of nephrotoxicity OTHER INFORMATION
Maintain adequate hydration to prevent renal toxicityMonitor serum calcium and magnesium Some units use full-dose ganciclovir and half-dose foscarnet concomitantly for treatment of resistant CMV disease
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home